Tenofovir-Associated Decline in Renal Function.

A letter to the editor is presented in response to the article "Greater tenofovir-associated renal function decline with protease inhibitor-based versus non-nucleoside reverse-transcriptase inhibitor-based therapy," by Miguel Goicoechea, Shanshan Liu, Brookie Best, and colleagues.